asal spray for patients with chronic rhinosinusitis undergoing (Functional Endoscopic Sinus Surgery) FESS

Not Applicable

• Conditions: Chronic rhinosinusitis; Respiratory - Other respiratory disorders / diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12621000707864
• Lead Sponsor: Richard Douglas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-08
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Chronic rhinosinusitis patients undergoing FESS due to CRS as defined by the 2020 European Position Paper on Rhinosinusitis and Nasal Polyps
-18 years or older
-Competent to give informed consent

Exclusion Criteria

-Patients with septal perforation
-Pre or postoperative severe septal deviation. If a septal deviation is present, it will not be easy to discern if nasal obstruction is due to a deviated septum or to another cause such as crusting or inflammation.
-Patients who have had previous FESS. Patients with recalcitrant sinus disease who need another surgery usually have a greater compromise of normal nasal physiology, reducing effectiveness of topical therapies.
-Patients with other underlying disease that affects respiratory mucosa such as cystic fibrosis, primary ciliary dyskinesia, or aspirin hypersensitivity
-Any known allergies or hypersensitivity to any of the components of the formulations.

Study & Design

• Study Type: Interventional
• Study Design: Not specified